Cohesin modulates transcription of estrogen-responsive genes

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1849, Issue 3, 2015, Pages 257-269

  Antony, Jisha ^a   Dasgupta, Tanushree ^a   Rhodes, Jenny M ^a   McEwan, Miranda V ^a   Print, Cristin G ^b   O'Sullivan, Justin M ^c   Horsfield, Julia A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Breast cancer; Chromatin; Cohesin; Estrogen receptor alpha; Transcription

Indexed keywords

COHESIN; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; MYC PROTEIN; CELL CYCLE PROTEINS; CHROMATIN; CHROMOSOMAL PROTEINS, NON-HISTONE; COHESINS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA, HUMAN; ESTROGENS;

ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DEFENSE MECHANISM; ENHANCER REGION; ESTROGEN RESPONSIVE ELEMENT; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE LOCUS; GENE REPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MCF 7 CELL LINE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; BIOSYNTHESIS; BREAST NEOPLASMS; CHROMATIN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETICS; HUMANS; MCF-7 CELLS; METABOLISM; PATHOLOGY; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC;

BREAST NEOPLASMS; CELL CYCLE PROTEINS; CHROMATIN; CHROMOSOMAL PROTEINS, NON-HISTONE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC;

EID: 84921477095     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2014.12.011     Document Type: Article

References (81)

1. Harmston N., Lenhard B. Chromatin and epigenetic features of long-range gene regulation. Nucleic Acids Res. 2013, 41:7185-7199.
2. Metivier R., Reid G., Gannon F. Transcription in four dimensions: nuclear receptor-directed initiation of gene expression. EMBO Rep. 2006, 7:161-167.
3. Dixon J.R., Selvaraj S., Yue F., Kim A., Li Y., Shen Y., Hu M., Liu J.S., Ren B. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 2012, 485:376-380.
4. Nora E.P., Lajoie B.R., Schulz E.G., Giorgetti L., Okamoto I., Servant N., Piolot T., van Berkum N.L., Meisig J., Sedat J., Gribnau J., Barillot E., Bluthgen N., Dekker J., Heard E. Spatial partitioning of the regulatory landscape of the X-inactivation centre. Nature 2012, 485:381-385.
5. Lieberman-Aiden E., van Berkum N.L., Williams L., Imakaev M., Ragoczy T., Telling A., Amit I., Lajoie B.R., Sabo P.J., Dorschner M.O., Sandstrom R., Bernstein B., Bender M.A., Groudine M., Gnirke A., Stamatoyannopoulos J., Mirny L.A., Lander E.S., Dekker J. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 2009, 326:289-293.
6. Gibcus Johan H., Dekker J. The hierarchy of the 3D genome. Mol. Cell 2013, 49:773-782.
7. Bose T., Gerton J.L. Cohesinopathies, gene expression, and chromatin organization. J. Cell Biol. 2010, 189:201-210.
8. Dorsett D. Cohesin: genomic insights into controlling gene transcription and development. Curr. Opin. Genet. Dev. 2011, 21:199-206.
9. Nasmyth K., Haering C.H. The structure and function of SMC and kleisin complexes. Annu. Rev. Biochem. 2005, 74:595-648.
10. Nasmyth K., Haering C.H. Cohesin: its roles and mechanisms. Annu. Rev. Genet. 2009, 43:525-558.
11. Horsfield J.A., Print C.G., Monnich M. Diverse developmental disorders from the one ring: distinct molecular pathways underlie the cohesinopathies. Front. Genet. 2012, 3:171.
12. Monnich M., Banks S., Eccles M., Dickinson E., Horsfield J. Expression of cohesin and condensin genes during zebrafish development supports a non-proliferative role for cohesin. Gene Expr. Patterns GEP 2009, 9:586-594.
13. Pauli A., Althoff F., Oliveira R.A., Heidmann S., Schuldiner O., Lehner C.F., Dickson B.J., Nasmyth K. Cell-type-specific TEV protease cleavage reveals cohesin functions in Drosophila neurons. Dev. Cell 2008, 14:239-251.
14. Pauli A., van Bemmel J.G., Oliveira R.A., Itoh T., Shirahige K., van Steensel B., Nasmyth K. A direct role for cohesin in gene regulation and ecdysone response in Drosophila salivary glands. Curr. Biol. CB 2010, 20:1787-1798.
15. Schuldiner O., Berdnik D., Levy J.M., Wu J.S., Luginbuhl D., Gontang A.C., Luo L. piggyBac-based mosaic screen identifies a postmitotic function for cohesin in regulating developmental axon pruning. Dev. Cell 2008, 14:227-238.
16. Wang C., Mayer J.A., Mazumdar A., Fertuck K., Kim H., Brown M., Brown P.H. Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor. Mol. Endocrinol. 2011, 25:1527-1538.
17. Faure A.J., Schmidt D., Watt S., Schwalie P.C., Wilson M.D., Xu H., Ramsay R.G., Odom D.T., Flicek P. Cohesin regulates tissue-specific expression by stabilizing highly occupied cis-regulatory modules. Genome Res. 2012, 22:2163-2175.
18. Horsfield J.A., Anagnostou S.H., Hu J.K., Cho K.H., Geisler R., Lieschke G., Crosier K.E., Crosier P.S. Cohesin-dependent regulation of Runx genes. Development 2007, 134:2639-2649.
19. Marsman J., O'Neill A.C., Kao B.R., Rhodes J.M., Meier M., Antony J., Monnich M., Horsfield J.A. Cohesin and CTCF differentially regulate spatiotemporal runx1 expression during zebrafish development. Biochim. Biophys. Acta 2014, 1839:50-61.
20. Chien R., Zeng W., Kawauchi S., Bender M.A., Santos R., Gregson H.C., Schmiesing J.A., Newkirk D.A., Kong X., Ball A.R., Calof A.L., Lander A.D., Groudine M.T., Yokomori K. Cohesin mediates chromatin interactions that regulate mammalian beta-globin expression. J. Biol. Chem. 2011, 286:17870-17878.
21. Feig C., Odom D.T. Cohesin's role as an active chromatin domain anchorage revealed. EMBO J. 2013, 32:3114-3115.
22. Hadjur S., Williams L.M., Ryan N.K., Cobb B.S., Sexton T., Fraser P., Fisher A.G., Merkenschlager M. Cohesins form chromosomal cis-interactions at the developmentally regulated IFNG locus. Nature 2009, 460:410-413.
23. Hou C., Dale R., Dean A. Cell type specificity of chromatin organization mediated by CTCF and cohesin. Proc. Natl. Acad. Sci. 2010, 107:3651-3656.
24. Nativio R., Wendt K.S., Ito Y., Huddleston J.E., Uribe-Lewis S., Woodfine K., Krueger C., Reik W., Peters J.-M., Murrell A. Cohesin is required for higher-order chromatin conformation at the imprinted IGF2-H19 locus. PLoS Genet. 2009, 5:e1000739.
25. Schmidt D., Schwalie P.C., Ross-Innes C.S., Hurtado A., Brown G.D., Carroll J.S., Flicek P., Odom D.T. A CTCF-independent role for cohesin in tissue-specific transcription. Genome Res. 2010, 20:578-588.
26. Seitan V.C., Faure A.J., Zhan Y., McCord R.P., Lajoie B.R., Ing-Simmons E., Lenhard B., Giorgetti L., Heard E., Fisher A.G., Flicek P., Dekker J., Merkenschlager M. Cohesin-based chromatin interactions enable regulated gene expression within preexisting architectural compartments. Genome Res. 2013, 23:2066-2077.
27. Sofueva S., Yaffe E., Chan W.C., Georgopoulou D., Vietri Rudan M., Mira-Bontenbal H., Pollard S.M., Schroth G.P., Tanay A., Hadjur S. Cohesin-mediated interactions organize chromosomal domain architecture. EMBO J. 2013, 32:3119-3129.
28. Zuin J., Dixon J.R., van der Reijden M.I.J.A., Ye Z., Kolovos P., Brouwer R.W.W., van de Corput M.P.C., van de Werken H.J.G., Knoch T.A., van IJcken W.F.J., Grosveld F.G., Ren B., Wendt K.S. Cohesin and CTCF differentially affect chromatin architecture and gene expression in human cells. Proc. Natl. Acad. Sci. 2013, 111:996-1001.
29. Dowen J.M., Fan Z.P., Hnisz D., Ren G., Abraham B.J., Zhang L.N., Weintraub A.S., Schuijers J., Lee T.I., Zhao K., Young R.A. Control of cell identity genes occurs in insulated neighborhoods in Mammalian chromosomes. Cell 2014, 159:374-387.
30. Losada A. Cohesin in cancer: chromosome segregation and beyond. Nat. Rev. Cancer 2014, 14:389-393.
31. Rhodes J.M., McEwan M., Horsfield J.A. Gene regulation by cohesin in cancer: is the ring an unexpected party to proliferation?. Mol. Cancer Res. MCR 2011, 9:1587-1607.
32. Kon A., Shih L.Y., Minamino M., Sanada M., Shiraishi Y., Nagata Y., Yoshida K., Okuno Y., Bando M., Nakato R., Ishikawa S., Sato-Otsubo A., Nagae G., Nishimoto A., Haferlach C., Nowak D., Sato Y., Alpermann T., Nagasaki M., Shimamura T., Tanaka H., Chiba K., Yamamoto R., Yamaguchi T., Otsu M., Obara N., Sakata-Yanagimoto M., Nakamaki T., Ishiyama K., Nolte F., Hofmann W.K., Miyawaki S., Chiba S., Mori H., Nakauchi H., Koeffler H.P., Aburatani H., Haferlach T., Shirahige K., Miyano S., Ogawa S. Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms. Nat. Genet. 2013, 45:1232-1237.
33. Leeke B., Marsman J., O' Sullivan J.M., Horsfield J.A. Cohesin mutations in myeloid malignancies: underlying mechanisms. Exp. Hematol. Oncol. 2014, 3:13.
34. Thol F., Bollin R., Gehlhaar M., Walter C., Dugas M., Suchanek K.J., Kirchner A., Huang L., Chaturvedi A., Wichmann M., Wiehlmann L., Shahswar R., Damm F., Gohring G., Schlegelberger B., Schlenk R., Dohner K., Dohner H., Krauter J., Ganser A., Heuser M. Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications. Blood 2014, 123:914-920.
35. Barber T.D., McManus K., Yuen K.W.Y., Reis M., Parmigiani G., Shen D., Barrett I., Nouhi Y., Spencer F., Markowitz S., Velculescu V.E., Kinzler K.W., Vogelstein B., Lengauer C., Hieter P. Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers. Proc. Natl. Acad. Sci. 2008, 105:3443-3448.
36. Xu H., Yan M., Patra J., Natrajan R., Yan Y., Swagemakers S., Tomaszewski J.M., Verschoor S., Millar E.K., van der Spek P., Reis-Filho J.S., Ramsay R.G., O'Toole S.A., McNeil C.M., Sutherland R.L., McKay M.J., Fox S.B. Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers. Breast Cancer Res. BCR 2011, 13:R9.
37. Atienza J.M., Roth R.B., Rosette C., Smylie K.J., Kammerer S., Rehbock J., Ekblom J., Denissenko M.F. Suppression of RAD21 gene expression decreases cell growth and enhances cytotoxicity of etoposide and bleomycin in human breast cancer cells. Mol. Cancer Ther. 2005, 4:361-368.
38. Xu H., Tomaszewski J.M., McKay M.J. Can corruption of chromosome cohesion create a conduit to cancer?. Nat. Rev. Cancer 2011, 11:199-210.
39. Carroll J.S., Brown M. Estrogen receptor target gene: an evolving concept. Mol. Endocrinol. (Baltimore Md.) 2006, 20:1707-1714.
40. Theodorou V., Stark R., Menon S., Carroll J.S. GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility. Genome Res. 2013, 23:12-22.
41. Fullwood M.J., Liu M.H., Pan Y.F., Liu J., Xu H., Mohamed Y.B., Orlov Y.L., Velkov S., Ho A., Mei P.H., Chew E.G.Y., Huang P.Y.H., Welboren W.-J., Han Y., Ooi H.S., Ariyaratne P.N., Vega V.B., Luo Y., Tan P.Y., Choy P.Y., Wansa K.D.S.A., Zhao B., Lim K.S., Leow S.C., Yow J.S., Joseph R., Li H., Desai K.V., Thomsen J.S., Lee Y.K., Karuturi R.K.M., Herve T., Bourque G., Stunnenberg H.G., Ruan X., Cacheux-Rataboul V., Sung W.-K., Liu E.T., Wei C.-L., Cheung E., Ruan Y. An oestrogen-receptor-α-bound human chromatin interactome. Nature 2009, 462:58-64.
42. Pan Y.F., Wansa K.D., Liu M.H., Zhao B., Hong S.Z., Tan P.Y., Lim K.S., Bourque G., Liu E.T., Cheung E. Regulation of estrogen receptor-mediated long range transcription via evolutionarily conserved distal response elements. J. Biol. Chem. 2008, 283:32977-32988.
43. Carroll J.S., Liu X.S., Brodsky A.S., Li W., Meyer C.A., Szary A.J., Eeckhoute J., Shao W., Hestermann E.V., Geistlinger T.R., Fox E.A., Silver P.A., Brown M. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 2005, 122:33-43.
44. Carroll J.S., Meyer C.A., Song J., Li W., Geistlinger T.R., Eeckhoute J., Brodsky A.S., Keeton E.K., Fertuck K.C., Hall G.F., Wang Q., Bekiranov S., Sementchenko V., Fox E.A., Silver P.A., Gingeras T.R., Liu X.S., Brown M. Genome-wide analysis of estrogen receptor binding sites. Nat. Genet. 2006, 38:1289-1297.
45. Klinge C.M. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res. 2001, 29:2905-2919.
46. McEwan M.V., Eccles M.R., Horsfield J.A. Cohesin is required for activation of MYC by estradiol. PLoS ONE 2012, 7:e49160.
47. Rhodes J.M., Bentley F.K., Print C.G., Dorsett D., Misulovin Z., Dickinson E.J., Crosier K.E., Crosier P.S., Horsfield J.A. Positive regulation of c-Myc by cohesin is direct, and evolutionarily conserved. Dev. Biol. 2010, 344:637-649.
48. Liu J., Zhang Z., Bando M., Itoh T., Deardorff M.A., Clark D., Kaur M., Tandy S., Kondoh T., Rappaport E., Spinner N.B., Vega H., Jackson L.G., Shirahige K., Krantz I.D. Transcriptional dysregulation in NIPBL and cohesin mutant human cells. PLoS Biol. 2009, 7:e1000119.
49. Xu B., Lee K.K., Zhang L., Gerton J.L. Stimulation of mTORC1 with L-leucine rescues defects associated with Roberts syndrome. PLoS Genet. 2013, 9:e1003857.
50. Baselga J. Targeting the phosphoinositide-3 (PI3) kinase pathway in breast cancer. Oncologist 2011, 16(Suppl. 1):12-19.
51. Guertin D.A., Sabatini D.M. An expanding role for mTOR in cancer. Trends Mol. Med. 2005, 11:353-361.
52. Olayioye M.A., Neve R.M., Lane H.A., Hynes N.E. The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J. 2000, 19:3159-3167.
53. Forget M.A., Turcotte S., Beauseigle D., Godin-Ethier J., Pelletier S., Martin J., Tanguay S., Lapointe R. The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types. Br. J. Cancer 2007, 96:646-653.
54. Gibson S.L., Ma Z., Shaw L.M. Divergent roles for IRS-1 and IRS-2 in breast cancer metastasis. Cell cycle (Georgetown Tex.) 2007, 6:631-637.
55. Hsu Y.-H., Hsing C.-H., Li C.-F., Chan C.-H., Chang M.-C., Yan J.-J., Chang M.-S. Anti-IL-20 monoclonal antibody suppresses breast cancer progression and bone osteolysis in murine models. J. Immunol. 2012, 188:1981-1991.
56. Hyder S.M., Liang Y., Wu J. Estrogen regulation of thrombospondin-1 in human breast cancer cells. Int. J. Cancer 2009, 125:1045-1053.
57. Luker K.E., Luker G.D. Functions of CXCL12 and CXCR4 in breast cancer. Cancer Lett. 2006, 238:30-41.
58. Nadler Y., Camp R.L., Giltnane J.M., Moeder C., Rimm D.L., Kluger H.M., Kluger Y. Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer. Breast Cancer Res. BCR 2008, 10:R35.
59. Owens P., Pickup M.W., Novitskiy S.V., Chytil A., Gorska A.E., Aakre M.E., West J., Moses H.L. Disruption of bone morphogenetic protein receptor 2 (BMPR2) in mammary tumors promotes metastases through cell autonomous and paracrine mediators. Proc. Natl. Acad. Sci. 2011, 109:2814-2819.
60. Zhang J., Liang Q., Lei Y., Yao M., Li L., Gao X., Feng J., Zhang Y., Gao H., Liu D.-X., Lu J., Huang B. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression. Cancer Res. 2012, 72:4597-4608.
61. Zhang Y., Liang J., Li Y., Xuan C., Wang F., Wang D., Shi L., Zhang D., Shang Y. CCCTC-binding factor acts upstream of FOXA1 and demarcates the genomic response to estrogen. J. Biol. Chem. 2010, 285:28604-28613.
62. Kininis M., Isaacs G.D., Core L.J., Hah N., Kraus W.L. Postrecruitment regulation of RNA polymerase II directs rapid signaling responses at the promoters of estrogen target genes. Mol. Cell. Biol. 2009, 29:1123-1133.
63. Phatnani H.P., Greenleaf A.L. Phosphorylation and functions of the RNA polymerase II CTD. Genes Dev. 2006, 20:2922-2936.
64. Fay A., Misulovin Z., Li J., Schaaf Cheri A., Gause M., Gilmour David S., Dorsett D. Cohesin selectively binds and regulates genes with paused RNA polymerase. Curr. Biol. 2011, 21:1624-1634.
65. Schaaf C.A., Kwak H., Koenig A., Misulovin Z., Gohara D.W., Watson A., Zhou Y., Lis J.T., Dorsett D. Genome-wide control of RNA polymerase II activity by cohesin. PLoS Genet. 2013, 9:e1003382.
66. Wang C., Mayer J.A., Mazumdar A., Fertuck K., Kim H., Brown M., Brown P.H. Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor. Mol. Endocrinol. (Baltimore Md.) 2011, 25:1527-1538.
67. Li W., Notani D., Ma Q., Tanasa B., Nunez E., Chen A.Y., Merkurjev D., Zhang J., Ohgi K., Song X., Oh S., Kim H.-S., Glass C.K., Rosenfeld M.G. Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature 2013, 498:516-520.
68. Quintin J., Le Peron C., Palierne G., Bizot M., Cunha S., Serandour A.A., Avner S., Henry C., Percevault F., Belaud-Rotureau M.A., Huet S., Watrin E., Eeckhoute J., Legagneux V., Salbert G., Metivier R. Dynamic estrogen receptor interactomes control estrogen-responsive trefoil factor (TFF) locus cell-specific activities. Mol. Cell. Biol. 2014, 34:2418-2436.
69. Ahmed S., Al-Saigh S., Matthews J. FOXA1 is essential for aryl hydrocarbon receptor-dependent regulation of cyclin G2. Mol. Cancer Res. MCR 2012, 10:636-648.
70. Pfister T.D., Reinhold W.C., Agama K., Gupta S., Khin S.A., Kinders R.J., Parchment R.E., Tomaszewski J.E., Doroshow J.H., Pommier Y. Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity. Mol. Cancer Ther. 2009, 8:1878-1884.
71. Howe L.R., Brown P.H. Targeting the HER/EGFR/ErbB family to prevent breast cancer. Cancer Prev. Res. 2011, 4:1149-1157.
72. Yao E.S., Zhang H., Chen Y.Y., Lee B., Chew K., Moore D., Park C. Increased beta1 integrin is associated with decreased survival in invasive breast cancer. Cancer Res. 2007, 67:659-664.
73. Deb S., Xu H., Tuynman J., George J., Yan Y., Li J., Ward R.L., Mortensen N., Hawkins N.J., McKay M.J., Ramsay R.G., Fox S.B. RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas. Br. J. Cancer 2014, 110:1606-1613.
74. Marsman J., Horsfield J.A. Long distance relationships: enhancer-promoter communication and dynamic gene transcription. Biochim. Biophys. Acta 2012, 1819:1217-1227.
75. Zhang Y., Wong C.H., Birnbaum R.Y., Li G., Favaro R., Ngan C.Y., Lim J., Tai E., Poh H.M., Wong E., Mulawadi F.H., Sung W.K., Nicolis S., Ahituv N., Ruan Y., Wei C.L. Chromatin connectivity maps reveal dynamic promoter-enhancer long-range associations. Nature 2013, 504:306-310.
76. Fullwood M.J., Ruan Y. ChIP-based methods for the identification of long-range chromatin interactions. J. Cell. Biochem. 2009, 107:30-39.
77. Karam S.M., Tomasetto C., Rio M.-C. Trefoil factor 1 is required for the commitment programme of mouse oxyntic epithelial progenitors. Gut 2004, 53:1408-1415.
78. Hu Q., Kwon Y.-S., Nunez E., Cardamone M.D., Hutt K.R., Ohgi K.A., Garcia-Bassets I., Rose D.W., Glass C.K., Rosenfeld M.G., Fu X.-D. Enhancing nuclear receptor-induced transcription requires nuclear motor and LSD1-dependent gene networking in interchromatin granules. Proc. Natl. Acad. Sci. 2008, 105:19199-19204.
79. Le Dily F., Baù D., Pohl A., Vicent G.P., Soronellas D., Castellano G., Serra F., Wright R.H.G., Ballare C.J., Filion G., Marti-Renom M.A., Beato M. Distinct structural transitions of chromatin topological domains coordinate hormone-induced gene regulation, bioRxiv 2014.
80. Schaaf C.A., Misulovin Z., Gause M., Koenig A., Gohara D.W., Watson A., Dorsett D. Cohesin and polycomb proteins functionally interact to control transcription at silenced and active genes. PLoS Genet. 2013, 9:e1003560.
81. Schaaf C.A., Misulovin Z., Sahota G., Siddiqui A.M., Schwartz Y.B., Kahn T.G., Pirrotta V., Gause M., Dorsett D. Regulation of the Drosophila enhancer of split and invected-engrailed gene complexes by sister chromatid cohesion proteins. PLoS ONE 2009, 4:e6202.